ETCM
IONS icon

Evolutionary Tree Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Evolutionary Tree Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-39,841
Closed -$2.25M – 42
2020
Q4 		$2.25M Buy
+39,841
New +$1.99M 1.72% 25

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Evolutionary Tree Capital Management's IONS Position: Q1 2021 in Review

Evolutionary Tree Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 39,841 shares — an estimated $2.25M sold.

Evolutionary Tree Capital Management first reported a position in IONS in Q4 2020 and held it in 1 quarter. The position peaked at $2.25M in Q4 2020. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Evolutionary Tree Capital Management reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Evolutionary Tree Capital Management sold 39,841 Ionis Pharmaceuticals shares in Q1 2021, an estimated $2.25M.
  • Evolutionary Tree Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Evolutionary Tree Capital Management's Ionis Pharmaceuticals position peaked at $2.25M in Q4 2020.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Evolutionary Tree Capital Management's 13F filing for Q1 2021, filed 14 May 2021.